Cargando…
Antibiotic drug discovery
Due to the threat posed by the increase of highly resistant pathogenic bacteria, there is an urgent need for new antibiotics; all the more so since in the last 20 years, the approval for new antibacterial agents had decreased. The field of natural product discovery has undergone a tremendous develop...
Autores principales: | Wohlleben, Wolfgang, Mast, Yvonne, Stegmann, Evi, Ziemert, Nadine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4993170/ https://www.ncbi.nlm.nih.gov/pubmed/27470984 http://dx.doi.org/10.1111/1751-7915.12388 |
Ejemplares similares
-
Actinomycetes: The Antibiotics Producers
por: Mast, Yvonne, et al.
Publicado: (2019) -
The Antibiotic Resistant Target Seeker (ARTS), an exploration engine for antibiotic cluster prioritization and novel drug target discovery
por: Alanjary, Mohammad, et al.
Publicado: (2017) -
Editorial: Regulation of Antibiotic Production in Actinomycetes
por: Mast, Yvonne, et al.
Publicado: (2020) -
Secondary Metabolite Transcriptomic Pipeline (SeMa-Trap), an expression-based exploration tool for increased secondary metabolite production in bacteria
por: Mungan, Mehmet Direnç, et al.
Publicado: (2022) -
ARTS-DB: a database for antibiotic resistant targets
por: Mungan, Mehmet Direnç, et al.
Publicado: (2021)